Recon: Texas AG sues insulin makers, PBMs over high costs; Lilly resolves US weight-loss drug shortages

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyReimbursementShortagesUnited States